262 related articles for article (PubMed ID: 29417293)
1. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Recio-Boiles A; Galeas JN; Goldwasser B; Sanchez K; Man LMW; Gentzler RD; Gildersleeve J; Hollen PJ; Gralla RJ
Support Care Cancer; 2018 Jul; 26(7):2353-2359. PubMed ID: 29417293
[TBL] [Abstract][Full Text] [Related]
2. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of using chest computed tomography (CT) imaging at the first lumbar vertebra (L1) level to assess skeletal muscle mass: a retrospective study.
Liu S; Han X; Li J; Xie X; Yang Y; Jiang W; Liu L; Liu Z
PeerJ; 2023; 11():e16652. PubMed ID: 38099314
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population.
Derstine BA; Holcombe SA; Ross BE; Wang NC; Su GL; Wang SC
Sci Rep; 2018 Jul; 8(1):11369. PubMed ID: 30054580
[TBL] [Abstract][Full Text] [Related]
6. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
[TBL] [Abstract][Full Text] [Related]
7. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT.
Kim EY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM; Kim JH
Support Care Cancer; 2016 Nov; 24(11):4721-6. PubMed ID: 27364150
[TBL] [Abstract][Full Text] [Related]
9. A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer.
Grønberg BH; Sjøblom B; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Eur J Clin Nutr; 2019 Jul; 73(7):1069-1076. PubMed ID: 30254241
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis.
Xu Z; Yang D; Luo J; Xu H; Jia J; Yang Z
J Magn Reson Imaging; 2023 Nov; 58(5):1569-1578. PubMed ID: 36932680
[TBL] [Abstract][Full Text] [Related]
11. Defining Normal Ranges of Skeletal Muscle Area and Skeletal Muscle Index in Children on CT Using an Automated Deep Learning Pipeline: Implications for Sarcopenia Diagnosis.
Somasundaram E; Castiglione JA; Brady SL; Trout AT
AJR Am J Roentgenol; 2022 Aug; 219(2):326-336. PubMed ID: 35234481
[No Abstract] [Full Text] [Related]
12. Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study.
Kong M; Geng N; Zhou Y; Lin N; Song W; Xu M; Li S; Piao Y; Han Z; Guo R; Yang C; Luo N; Wang Z; Jiang M; Wang L; Qiu W; Li J; Shi D; Li R; Cheung EC; Chen Y; Duan Z
Clin Nutr; 2022 Feb; 41(2):396-404. PubMed ID: 34999334
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
15. Validation for measurements of skeletal muscle areas using low-dose chest computed tomography.
Lim WH; Park CM
Sci Rep; 2022 Jan; 12(1):463. PubMed ID: 35013501
[TBL] [Abstract][Full Text] [Related]
16. Comparison of CT derived body composition at the thoracic T4 and T12 with lumbar L3 vertebral levels and their utility in patients with rectal cancer.
Arayne AA; Gartrell R; Qiao J; Baird PN; Yeung JM
BMC Cancer; 2023 Jan; 23(1):56. PubMed ID: 36647027
[TBL] [Abstract][Full Text] [Related]
17. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
[TBL] [Abstract][Full Text] [Related]
18. The association between L1 skeletal muscle index derived from routine CT and in-hospital mortality in CAP patients in the ED.
Han JW; Song H; Kim SH
Am J Emerg Med; 2021 Apr; 42():49-54. PubMed ID: 33450707
[TBL] [Abstract][Full Text] [Related]
19. Fully Automated Deep Learning Tool for Sarcopenia Assessment on CT: L1 Versus L3 Vertebral Level Muscle Measurements for Opportunistic Prediction of Adverse Clinical Outcomes.
Pickhardt PJ; Perez AA; Garrett JW; Graffy PM; Zea R; Summers RM
AJR Am J Roentgenol; 2022 Jan; 218(1):124-131. PubMed ID: 34406056
[No Abstract] [Full Text] [Related]
20. CT-based screening of sarcopenia and its role in cachexia syndrome in pancreatic cancer.
Khristenko E; Sinitsyn V; Rieden T; Girod P; Kauczor HU; Mayer P; Klauss M; Lyadov V
PLoS One; 2024; 19(1):e0291185. PubMed ID: 38271373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
